ALTERITY THERAPEUTICS LIMITED (ATHE)

Every figure this model derived for ATHE, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 5,722 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2024-06-30
cash 33,200,457 CashAndCashEquivalents 2025-06-30
current assets 45,871,186 CurrentAssets 2025-06-30
current liabilities 3,534,729 CurrentLiabilities 2025-06-30
equity -225,888,680 EquityAttributableToOwnersOfParent 2025-06-30
interest expense 6,188 InterestExpense 2025-06-30
ocf -11,451,248 CashFlowsFromUsedInOperatingActivities 2025-06-30
revenue 446,291 RevenueFromInterest 2025-06-30
sbc 979,920 ExpenseFromSharebasedPaymentTransactionsWithEmployees 2025-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up ATHE on one particular measure came for.

RatioValue
current ratio12.98
current ratio reported12.98
dilution pct75.38
revenue growth66.27
revenue growth per share-5.2
sbc pct revenue219.57

What to be careful about

What this model itself distrusts about ATHE's figures. Written by the derivation as it ran, not added afterwards.